Business NewsPR NewsWire • Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients

Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients

Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients

BRUSSELS, Oct. 31, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the detailed results of the head-to-head Phase 3 BE SURE study, which demonstrated that patients treated with investigational IL-17A and IL-17F inhibitor bimekizumab achieved superior skin...

View More : https://www.prnewswire.com:443/news-releases/bimekizumab-phase-3-data-shows-superior-skin-clearance-over-humira-in-moder...
Releted News by prnewswire
Healing Nature: Photography by Ansel Adams, Dorothea Lange, and Toyo Miyatake Explores the Power of Gardens
Get Your Gaffer Tape Ready: Tape Face Is Back
Two Landmark Studies Advance Focused Ultrasound Treatment for Parkinson's Disease
Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients
Exchange between ChantsWood (Beijing) Information Technology Co., Ltd. and ZHOU Qian, Renowned Chinese Expert on Electric Power Communication
Dr. Fauci tells Annual Forum to be ready for a "painful winter" and says his spring prediction of '100,000 cases a day' is getting closer